Australia
· Delayed Price · Currency is AUD Tissue Repair Statistics
Total Valuation
Tissue Repair has a market cap or net worth of AUD 13.30 million. The enterprise value is -1.13 million.
| Market Cap | 13.30M |
| Enterprise Value | -1.13M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
| Earnings Date | May 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Tissue Repair has 60.46 million shares outstanding. The number of shares has decreased by -0.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 60.46M |
| Shares Change (YoY) | -0.16% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 14.39% |
| Owned by Institutions (%) | 8.82% |
| Float | 32.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.57 |
| PB Ratio | 0.85 |
| P/TBV Ratio | 0.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.25 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.21 |
Financial Position
The company has a current ratio of 14.99
| Current Ratio | 14.99 |
| Quick Ratio | 14.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -25.11% and return on invested capital (ROIC) is -19.56%.
| Return on Equity (ROE) | -25.11% |
| Return on Assets (ROA) | -18.55% |
| Return on Invested Capital (ROIC) | -19.56% |
| Return on Capital Employed (ROCE) | -35.49% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -4.35% in the last 52 weeks. The beta is 0.48, so Tissue Repair's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -4.35% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 0.30 |
| Relative Strength Index (RSI) | 27.74 |
| Average Volume (20 Days) | 98,762 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Tissue Repair had revenue of AUD 2.39 million and -4.44 million in losses. Loss per share was -0.07.
| Revenue | 2.39M |
| Gross Profit | 2.39M |
| Operating Income | -5.54M |
| Pretax Income | -4.44M |
| Net Income | -4.44M |
| EBITDA | -5.53M |
| EBIT | -5.54M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 14.43 million in cash and n/a in debt, giving a net cash position of 14.43 million or 0.24 per share.
| Cash & Cash Equivalents | 14.43M |
| Total Debt | n/a |
| Net Cash | 14.43M |
| Net Cash Per Share | 0.24 |
| Equity (Book Value) | 15.58M |
| Book Value Per Share | 0.26 |
| Working Capital | 15.59M |
Cash Flow
In the last 12 months, operating cash flow was -5.38 million and capital expenditures -10,040, giving a free cash flow of -5.39 million.
| Operating Cash Flow | -5.38M |
| Capital Expenditures | -10,040 |
| Free Cash Flow | -5.39M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 100.00%, with operating and profit margins of -231.99% and -186.12%.
| Gross Margin | 100.00% |
| Operating Margin | -231.99% |
| Pretax Margin | -186.12% |
| Profit Margin | -186.12% |
| EBITDA Margin | -231.85% |
| EBIT Margin | -231.99% |
| FCF Margin | n/a |
Dividends & Yields
Tissue Repair does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.16% |
| Shareholder Yield | 0.16% |
| Earnings Yield | -33.39% |
| FCF Yield | -40.53% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Tissue Repair has an Altman Z-Score of 7.52.
| Altman Z-Score | 7.52 |
| Piotroski F-Score | n/a |